Иммуноцитологический метод обнаружения диссеминированных опухолевых клеток в костном мозге у больных раком молочной железы
Богомолова Оксана Андреевна, Тупицын Николай Николаевич, Родионов Валерий Витальевич et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2014
The study was performed in 50 patients with I-IV stage breast cancer. Bone marrow assessment was made prior to treatment by standard morphological methods and flow cytometry using monoclonal anti-EpCAM antibodies (CD326). Flow cytometry was conducted after immunomagnetic enrichment of cells with anti-EpCAM antibodies. The presence of one or more disseminated tumor cells per 106 myelokaryocytes was established as threshold level. Standard cytological and histological study discovered bone marrow metastases in 1 (2.0%) and 2 (4.0%) of 50 patients, respectively. Flow cytometry confirmed bone marrow involvement in both cases and significantly improved detection rate of micrometastases and disseminated tumor cells to a total of 11 patients (22.0%). In our opinion flow cytometry is the method of choice for disseminated tumor cell measurement after immunomagnetic enrichment with anti-EpCAM antibodies, especially in patients with early stage breast cancer for assessment of disease advance and personalization of treatment.
Cited by 0 works.